PT
Protagonist Therapeutics Inc
🇺🇸XNAS.PTGXUnited StatesHealthcare
$143.40USDdown -4.38 (-2.96%)OpenEnd of day5:14 PM
Price$143.40-4.38 (-2.96%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US74366E1029
- CUSIP
- 74366E102
Company
- Employees
- 141
- Headquarters
- Newark, United States
- CEO
- Dr. Dinesh V. Patel Ph.D.
Market
- Shares outstanding
- 64.7M
- Market cap
- $9.28B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $9.28B
- EPS LTM
- $1.28calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 111.92calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $281.99M+34.81%up year on year
- Net income
- $82.91M+59.32%up year on year
- Gross margin
- 99.72%+0.01%up year on year
- Free cash flow
- $132.17M+256.27%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.